We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
-15.93%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$241M
AUM Growth
-$15.6M
(-6.1%)
Cap. Flow
+$23.6M
Cap. Flow
% of AUM
9.82%
Top 10 Holdings %
Top 10 Hldgs %
91.73%
Holding
20
New
2
Increased
5
Reduced
7
Closed
5
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$30.6M |
| 2 |
HCA Healthcare
HCA
|
+$29.5M |
| 3 |
Universal Health Services
UHS
|
+$19.5M |
| 4 |
Labcorp
LH
|
+$15.2M |
| 5 |
Molina Healthcare
MOH
|
+$9.04M |
Top Sells
| 1 |
Centene
CNC
|
+$22.1M |
| 2 |
CELG
Celgene Corp
CELG
|
+$16.3M |
| 3 |
Humana
HUM
|
+$11.5M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$11.1M |
| 5 |
CVS Health
CVS
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 88.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Elevance Health
ELV
$80.9B
| $47M | 19.5% |
178,776
-1,598
| -0.9% | -$439K |
|
|
2
HCA Healthcare
HCA
$82.3B
| $27.4M | 11.37% |
+219,983
| New | +$29.5M |
|
|
WCG
3
DELISTED
Wellcare Health Plans, Inc.
WCG
| $27M | 11.21% |
+114,337
| New | +$30.6M |
|
4
Zimmer Biomet
ZBH
$17.6B
| $26.9M | 11.16% |
266,888
+21,042
| +9% | +$2.37M |
|
|
5
Molina Healthcare
MOH
$11.7B
| $25.6M | 10.64% |
220,319
+68,951
| +46% | +$9.04M |
|
|
6
Universal Health Services
UHS
$9.15B
| $23.1M | 9.61% |
198,447
+155,168
| +359% | +$19.5M |
|
|
7
Labcorp
LH
$23.2B
| $16M | 6.66% |
147,801
+113,681
| +333% | +$15.2M |
|
|
8
CVS Health
CVS
$137B
| $11.2M | 4.65% |
170,912
-144,468
| -46% | -$10.8M |
|
9
Cencora
COR
$59.9B
| $8.68M | 3.61% |
116,687
-57,891
| -33% | -$4.99M |
|
10
Heron Therapeutics
HRTX
$89.1M
| $7.98M | 3.32% |
307,737
| – | – |
|
11
Medpace
MEDP
$15.4B
| $6.72M | 2.79% |
126,887
+40,217
| +46% | +$2.21M |
|
|
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
| $3.96M | 1.65% |
108,734
-11,426
| -10% | -$468K |
|
|
PDCO
13
DELISTED
Patterson Companies, Inc.
PDCO
| $3.54M | 1.47% |
180,021
-37,560
| -17% | -$877K |
|
|
FOLD
14
DELISTED
Amicus Therapeutics
FOLD
| $3.41M | 1.42% |
355,785
-47,170
| -12% | -$519K |
|
15
Travere Therapeutics
TVTX
$5.27B
| $2.29M | 0.95% |
100,985
-192,938
| -66% | -$4.8M |
|
16
Boston Scientific
BSX
$65.4B
| – | – |
-24,671
| Closed | -$950K |
|
|
17
Centene
CNC
$32.8B
| – | – |
-305,680
| Closed | -$22.1M |
|
|
18
Humana
HUM
$48B
| – | – |
-34,062
| Closed | -$11.5M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-79,856
| Closed | -$11.1M |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| – | – |
-182,027
| Closed | -$16.3M |
|
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Tavio Capital held 20 positions worth $241M, down 6.1% from $256M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Tavio Capital deployed $23.6M of net new capital in Q4 2018, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was Wellcare Health Plans, Inc.: 114,337 shares worth $27M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 100% a quarter earlier.
On the sell side, the largest reduction was CVS Health, an estimated $10.8M trimmed.
- Tavio Capital's largest Q4 2018 buy was Wellcare Health Plans, Inc.: 114,337 shares worth $27M.
- Tavio Capital added most to Universal Health Services in Q4 2018, an estimated $19.5M increase.
- Tavio Capital's biggest Q4 2018 reduction was CVS Health, cutting an estimated $10.8M.
- Tavio Capital fully exited Centene in Q4 2018, selling an estimated $22.1M.
- Tavio Capital's ten largest holdings make up 92% of its $241M portfolio in Q4 2018.
- Tavio Capital opened 2 new positions and closed 5 in Q4 2018.
- Tavio Capital's portfolio value fell 6.1% quarter-over-quarter to $241M.
Based on Tavio Capital's 13F filing for Q4 2018, filed 14 Feb 2019.